Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells
- 1 March 1991
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 45 (3) , 252-257
- https://doi.org/10.1002/jcb.240450305
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Transplantation of Human Fetal Dopamine Cells for Parkinson's DiseaseArchives of Neurology, 1990
- Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's DiseaseScience, 1990
- Transplantation strategies in the treatment of Parkinson's disease: experimental basis and clinical trialsActa Neurologica Scandinavica, 1989
- Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients With Severe Parkinson's DiseaseArchives of Neurology, 1989
- EMBRYOS AND PARKINSON'S DISEASEThe Lancet, 1988
- Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.Molecular and Cellular Biology, 1988
- Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.Molecular and Cellular Biology, 1986
- Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplantsBrain Research, 1979
- Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine SystemScience, 1979
- Postsynaptic Supersensitivity after 6‐Hydroxy‐dopamine Induced Degeneration of the Nigro‐striatal Dopamine SystemActa Physiologica Scandinavica, 1971